Redirecting Specificity of T-Cell Populations For CD19 Using the Sleeping Beauty System
H Singh, PR Manuri, S Olivares, N Dara, MJ Dawson… - Cancer research, 2008 - AACR
Genetic modification of clinical-grade T cells is undertaken to augment function, including
redirecting specificity for desired antigen. We and others have introduced a chimeric antigen …
redirecting specificity for desired antigen. We and others have introduced a chimeric antigen …
[HTML][HTML] Preferential delivery of the Sleeping Beauty transposon system to livers of mice by hydrodynamic injection
JB Bell, KM Podetz-Pedersen, EL Aronovich… - Nature protocols, 2007 - nature.com
Nonviral, DNA-mediated gene transfer is an alternative to viral delivery systems for
expressing new genes in cells and tissues. The Sleeping Beauty (SB) transposon system …
expressing new genes in cells and tissues. The Sleeping Beauty (SB) transposon system …
Helper-independent piggyBac plasmids for gene delivery approaches: Strategies for avoiding potential genotoxic effects
J Urschitz, M Kawasumi, J Owens… - Proceedings of the …, 2010 - National Acad Sciences
Efficient integration of functional genes is an essential prerequisite for successful gene
delivery such as cell transfection, animal transgenesis, and gene therapy. Gene delivery …
delivery such as cell transfection, animal transgenesis, and gene therapy. Gene delivery …
Gene Expression in Lung and Liver After Intravenous Infusion of Polyethylenimine Complexes of Sleeping Beauty Transposons
KM Podetz-Pedersen, JB Bell, TWJ Steele… - Human gene …, 2010 - liebertpub.com
Two methods of systemic gene delivery have been extensively explored, using the mouse
as a model system: hydrodynamic delivery, wherein a DNA solution equivalent in volume to …
as a model system: hydrodynamic delivery, wherein a DNA solution equivalent in volume to …
[PDF][PDF] Development of Augmented Leukemia/Lymphoma-Specific T-Cell Immunotherapy for Deployment with Haploidentical, Hematompoietic Progenitor-Cell …
R Young - 2008 - researchgate.net
To develop T-cell therapies for B-cell malignancies we have developed a chimeric antigen
receptor (CAR) which when expressed on the cell surface redirects T-cell specificity for …
receptor (CAR) which when expressed on the cell surface redirects T-cell specificity for …